Fig. 7.

Ach reduces HCV core protein levels in HCV-infected live cells, but not in apoptotic bodies. A and B: HCV core protein (IB and quantification) in AGS-treated AB. C and D: HCV core protein (IB and quantification) in AGS-treated live cells. β-actin was used as internal control. E: infectivity of AB (immunostaining of HCV core protein in RLW cells infected with AB obtained from HCV⁺ untreated and treated cells). All data were generated from three independent experiments and presented as means ± SE. Bars with different letters are significantly different at P ≤ 0.05.